Dyssegmental dysplasia, Silverman-Handmaker type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1865OMIM:224410Q77.7
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Dyssegmental dysplasia, Silverman-Handmaker type (DDSH) is a rare, severe, and typically lethal skeletal dysplasia characterized by profound abnormalities in skeletal development, particularly affecting the vertebral column and long bones. It is caused by homozygous or compound heterozygous mutations in the HSPG2 gene, which encodes perlecan, a major heparan sulfate proteoglycan of basement membranes and cartilage. The disorder is also known as dyssegmental dwarfism, Silverman-Handmaker type, or dyssegmental dysplasia with glaucoma. Clinical features are apparent at birth and include severe short-limbed dwarfism, marked micromelia, a narrow thorax, and distinctive vertebral anomalies with irregular and disorganized vertebral body ossification (anisospondyly). Affected infants typically have a flat face, micrognathia, cleft palate, and encephalocele or occipital skull defects. Additional findings may include congenital glaucoma, joint contractures, and reduced joint mobility. The long bones are short and broad with irregular metaphyses. Internal organ abnormalities may also be present. The prognosis for DDSH is very poor, with most affected individuals dying in the neonatal period or early infancy due to respiratory insufficiency related to the severely narrow thorax and pulmonary hypoplasia. There is no specific curative treatment; management is supportive and palliative. Genetic counseling is important for affected families, as the condition follows autosomal recessive inheritance. Prenatal diagnosis may be possible through molecular testing or ultrasonographic detection of skeletal abnormalities.

Clinical phenotype terms— hover any for plain English:

AnisospondylyHP:0002879Bowing of the legsHP:0002979Abnormality of limbsHP:0040064
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Dyssegmental dysplasia, Silverman-Handmaker type.

View clinical trials →

No actively recruiting trials found for Dyssegmental dysplasia, Silverman-Handmaker type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Dyssegmental dysplasia, Silverman-Handmaker type community →

No specialists are currently listed for Dyssegmental dysplasia, Silverman-Handmaker type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Dyssegmental dysplasia, Silverman-Handmaker type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Dyssegmental dysplasia, Silverman-Handmaker typeForum →

No community posts yet. Be the first to share your experience with Dyssegmental dysplasia, Silverman-Handmaker type.

Start the conversation →

Latest news about Dyssegmental dysplasia, Silverman-Handmaker type

No recent news articles for Dyssegmental dysplasia, Silverman-Handmaker type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Dyssegmental dysplasia, Silverman-Handmaker type

What is Dyssegmental dysplasia, Silverman-Handmaker type?

Dyssegmental dysplasia, Silverman-Handmaker type (DDSH) is a rare, severe, and typically lethal skeletal dysplasia characterized by profound abnormalities in skeletal development, particularly affecting the vertebral column and long bones. It is caused by homozygous or compound heterozygous mutations in the HSPG2 gene, which encodes perlecan, a major heparan sulfate proteoglycan of basement membranes and cartilage. The disorder is also known as dyssegmental dwarfism, Silverman-Handmaker type, or dyssegmental dysplasia with glaucoma. Clinical features are apparent at birth and include severe s

How is Dyssegmental dysplasia, Silverman-Handmaker type inherited?

Dyssegmental dysplasia, Silverman-Handmaker type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Dyssegmental dysplasia, Silverman-Handmaker type typically begin?

Typical onset of Dyssegmental dysplasia, Silverman-Handmaker type is neonatal. Age of onset can vary across affected individuals.